SLC25A32 and ovarian serous cystadenocarcinoma: Notably, we obtained mutation frequency data that are almost consistent with the UALCAN database because both have high SLC25A32 mutation frequency (Figure 4(c)) in lung adenocarcinoma, endometrial, HNSC, stomach, breast, colorectal, glioblastoma, and ovarian serous cystadenocarcinoma (OV).